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Abstract:   14 
The ability to infect a host is a key trait of a virus, and differences in infectivity could 15 
put one virus at an evolutionary advantage over another. In this study we have 16 
quantified the infectivity of two strains of infectious hematopoietic necrosis virus (IHNV) 17 
that are known to differ in fitness and virulence. By exposing juvenile rainbow trout 18 
(Oncorhynchus mykiss) hosts to a wide range of virus doses, we were able to calculate 19 
the infectious dose in terms of ID50 values for the two genotypes. Lethal dose 20 
experiments were also conducted to confirm the virulence difference between the two 21 
virus genotypes, using a range of virus doses and holding fish either in isolation or in 22 
batch so as to calculate LD50 values. We found that infectivity is positively correlated 23 
with virulence, with the more virulent genotype having higher infectivity. Additionally, 24 
infectivity increases more steeply over a short range of doses compared to virulence, 25 
which has a shallower increase. We also examined the data using models of virion 26 
interaction and found no evidence to suggest that virions have either an antagonistic or 27 
a synergistic effect on each other, supporting the independent action hypothesis in the 28 
process of IHNV infection of rainbow trout. 29 
 © 2015. This manuscript version is made available under the Elsevier user license
http://www.elsevier.com/open-access/userlicense/1.0/
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1. Introduction 35 
 36 
 The ability to infect a host is necessary for a virus to propagate, and if one virus 37 
strain can do so better, it will likely have a competitive advantage over other strains. 38 
Certainly, a variety of other parameters also contribute to the absolute fitness of a 39 
virus, such as replication, shedding, and duration of infection, all of which are shaped 40 
by virus and host factors (Wargo & Kurath, 2012). However, without the important first 41 
step of host entry and initiation of infection these other parameters cannot be realized 42 
and viral fitness is diminished to zero. In this paper, we are concerned with infectivity, 43 
defined here as the ability of a pathogen to enter a host and begin replication, and 44 
virulence, defined here as the ability of a pathogen to kill its host. 45 
 A long-standing question has been the relationship between virus infectivity and 46 
virulence. However, few studies have examined how the relationship between virulence 47 
and infectivity might depend on virus exposure dosage. The paucity of such studies is 48 
surprising considering that it is well known that for viruses, infection and mortality are 49 
heavily shaped by exposure dose. In fact, because of the strong effect of exposure dose 50 
on disease outcome, viral virulence has often been characterized across a range of 51 
dosages. Such studies often calculate the 50% lethal dose (LD50), i.e., the virus dose at 52 
which fifty percent of exposed hosts die (Reed & Muench, 1938; Knittel, 1981; 53 
Engelking & Leong, 1989; LaPatra et al., 1993; Kim & Faisal, 2010). The LD50 is typically 54 
determined in a controlled experiment in which a range of exposure doses are 55 
administered to equivalent groups of hosts, and the resulting mortality at each dose is 56 
used to generate a dose-response curve and calculate the LD50 value. Such studies also 57 
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make it possible to quantify the minimum lethal dose, the lowest dose at which 58 
mortality is observed (Kothary & Babu, 2001; Ward et al., 1986).  59 
These LD50 studies are often used to make inferences about infectivity, assuming 60 
high virulence strains cause greater mortality because higher numbers of hosts become 61 
infected. However, this assumed relationship between virulence and infectivity has 62 
several limitations. For example, many viruses cause disease that does not result in 63 
host death. Viruses can also cause sub-clinical infections, where the host becomes 64 
infected but suffers no clinical disease. For example, a study of infectious pancreatic 65 
necrosis virus in Atlantic salmon found that at low challenge dosages a larger 66 
percentage of fish become infected than succumb to mortality (Urquhart et al., 2008). 67 
Quantification of actual infection is thus critical for an accurate assessment of 68 
infectivity, which is an essential component of overall viral fitness. Infectivity can be 69 
quantified in much the same way as virulence. For example a range of viral exposure 70 
dosages can be administered, after which hosts can be tested for infection status at a 71 
specific time post-infection. The prevalence of infection at each exposure dose is then 72 
used to calculate the 50% infectious dose (ID50), i.e., the dose at which fifty percent of 73 
exposed hosts are infected. Though the methods used to detect infection are different, 74 
the ID50 is determined in the same manner as the LD50 (Reed & Muench, 1938). As with 75 
lethal dose, minimum infectious dose, the lowest dose needed to cause an infection, 76 
can also be quantified. Interpretation of virus infection studies is heavily dependent on 77 
the methods used, which differ in their sensitivity and specificity for live virus, viral 78 
genetic material, or host responses to infection. In this study we define infection as the 79 
presence of viral RNA in the host as detected by real-time reverse transcriptase qPCR.  80 
In general fewer studies have been conducted examining ID50 values compared 81 
to the number exploring LD50 values. Among studies that determine both ID50 and LD50 82 
values for various host:pathogen systems, the relationship between infectivity and 83 
virulence is not always consistent. For example, a study of avian influenza virus in wild 84 
duck and poultry found large host species effects on infectious dose, but within a host 85 
species, LD50 values were tightly coupled with ID50 values, suggesting virulence was 86 
correlated with infectivity (Swayne & Slemmons, 2008). However, in a study of Monkey 87 
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B virus in mice, the relationship between LD50 and ID50 was less consistent, with some 88 
of the strains with the lowest ID50 values having the highest LD50 values, suggesting 89 
virulence may be decoupled from infectivity (Ritchey et. al., 2005). Thus, investigation 90 
of infectivity and virulence for additional pathogens is of interest, and aquatic systems 91 
are ideal for experiments involving large numbers of hosts being exposed to a wide 92 
range of pathogen doses.  93 
Examination of infectivity and virulence across a range of virus exposure dosages 94 
is a powerful method for comparing the traits of different virus strains. Such studies 95 
make it possible to reveal differences in virulence and infectivity that might not be 96 
apparent at single exposure dosages. This is because mortality and infectivity may 97 
saturate at the same levels for different virus genotypes, but the rate of increase in 98 
infection and mortality across exposure dosages may be different. In addition, the 99 
relationship between infectivity and exposure dose allows for an assessment of whether 100 
or not individual virions interact during the process of infection. For example, if there is 101 
a linear increase in the rate of infection as dose increases, this suggests that virions do 102 
not impact the infectivity of other virions. Here this is referred to as the independent 103 
action model, also sometimes referred to as the mass-action principle (Regoes et al., 104 
2003; Schmid-Hempel, 2011). In contrast, if the rate of infection changes in a non-105 
linear manner as the number of virions in the exposure dose increases, this would 106 
suggest that the virions interact with each other either in a synergistic or an 107 
antagonistic manner, here referred to as an interaction model. If there is a synergistic 108 
interaction, that could result in an invasion threshold, with a threshold dose (Regoes et 109 
al., 2003; Schmid-Hempel, 2011). In this case, if the host receives less than the 110 
threshold dose it will not become infected, and infection can only occur when the dose 111 
meets or exceeds the threshold dose. Ultimately, whether infectivity follows the 112 
independent action or interaction model can have influence epidemiological predictions 113 
about disease risk and spread (Schmid-Hempel, 2011; van der Werf, 2011). 114 
Here we examined and compared prevalence of infection and mortality over a 115 
range of virus exposure doses to characterize the relationship between infectivity and 116 
virulence for an aquatic virus in fish hosts. We utilized a virus-host system that has 117 
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been well-studied in vivo, infectious hematopoietic necrosis virus (IHNV; order 118 
Mononegavirales, family Rhabdoviridae, genus Novirhabdovirus) in rainbow trout 119 
(Wargo et al., 2010; Kell et al., 2013; Peñaranda et al., 2009; Bootland & Leong, 2011; 120 
Zhang & Gui, 2015). In the western United States, IHNV is endemic in salmonid fish 121 
throughout a range from Alaska to California, as well as inland via rivers to Idaho 122 
(Bootland & Leong, 2011). Within this range three main genogroups occur: U, M, and L, 123 
each of which exhibit some host specificity (Kurath et al., 2003). Relevant to this study, 124 
the M genogroup is hypothesized to have arisen in rainbow trout (Kurath et al., 2003). 125 
Under certain conditions IHNV causes disease epidemics in salmonid fish, with mortality 126 
due to necrosis of the hematopoietic kidney and spleen tissues (Bootland & Leong, 127 
2011).  Variation in virulence of IHNV strains has been reported in several studies, most 128 
often tested using a single high virus exposure dose (LaPatra et al., 1993; Garver et al., 129 
2006; Wargo et al., 2010).  However, infectious dose has not been previously quantified 130 
for IHNV. 131 
We compared the infectious dose and lethal dose for two virus strains within the 132 
M genogroup of IHNV, previously characterized as having high virulence and low 133 
virulence in rainbow trout based on mortality caused to the host due to infection at a 134 
single, high challenge dose (Wargo et al., 2010). The rainbow trout used here were 135 
from an aquaculture stock that is not inbred, and thus provided a host background for 136 
testing viral traits that is relevant to field conditions. The two virus strains have been 137 
previously studied, and their virulence correlates positively with in-host viral replicative 138 
fitness, as well as host entry and shedding (Wargo et al., 2010; Wargo & Kurath, 2011). 139 
Here we exposed groups of juvenile rainbow trout to a range of doses of each genotype 140 
and then measured the infection prevalence, infection intensity, and daily mortality in 141 
order to quantify infectivity and analyze the relationship between exposure dose and 142 
both infection and mortality.  143 
Five in vivo infection experiments were conducted using standardized one-hour 144 
batch immersion challenges to assure uniform, consistent virus exposure of fish within 145 
each group. Three of the experiments were independent infectious dose assays that 146 
determined ID50 estimates and provided a measure of the variability in those estimates. 147 
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In these experiments fish were separated into isolated holding tanks after challenge to 148 
avoid cross-infection, and infection status was determined at 3 days post-exposure.  149 
The fourth experiment was a virulence assay that determined the lethal dose of each 150 
strain under the same isolation conditions used in the infectious dose assays, allowing 151 
direct comparison of ID50 and LD50 values for the two IHNV strains.  Finally, as a 152 
secondary goal of this study we conducted a virulence assay using standard batch 153 
holding conditions, for comparison with the results of the virulence assay with fish held 154 
in isolation. This provided insight into how much of the mortality observed in standard 155 
batch challenge studies is due to holding conditions or secondary fish-to-fish infection. 156 
The combined data provide a comparison of the relationship between infectivity and 157 
lethality of two strains of a virus of differing virulence and expand upon the previous 158 
work done on the ecological parameters of various genotypes in the M genogroup of 159 
IHNV (Troyer et al., 2008; Wargo et al., 2010; Wargo & Kurath, 2011; Kell et al., 2013).  160 
 161 
2. Materials and methods 162 
 163 
2.1. Virus and host 164 
 165 
 For this study, we used two isolates of IHNV that differ in virulence. The more 166 
virulent strain is 220-90, referred to as HV for “high virulence”; the less virulent strain is 167 
WRAC (alternate name, 039-82), referred to as LV for “low virulence” (Wargo et al., 168 
2010). Both strains were obtained from farmed rainbow trout in Idaho and have been 169 
previously characterized for virulence (LaPatra et al., 1994; Garver et al., 2006; Wargo 170 
et al., 2010). Over the glycoprotein gene of the virus there is 3.6% (58/1621 171 
nucleotides) divergence between HV and LV; over the entire genome, the divergence is 172 
2.8% (312/11,133 nucleotides) (Morzonov et al., 1995; Ammayappan et al., 2010). The 173 
preparation of viral stocks as well as quantification of viral titer has been previously 174 
described (Fijan et al., 1983; Batts & Winton, 1989; Troyer et al., 2008). 175 
 The fish were research-grade, juvenile, 1-3 g rainbow trout, provided by Dr. 176 
Scott LaPatra of Clear Springs Foods, Incorporated. The experiments were performed 177 
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on three different lots of fish from this source. Stock fish were maintained in flow-178 
through freshwater that had been sand filtered and UV irradiated. All experiments were 179 
conducted at 15 °C. All animal procedures were approved by the University of 180 
Washington Institutional Animal Care and Use Committee. 181 
 182 
2.2. Virus challenges to determine infectious dose 183 
 184 
 Three experiments to determine the infectious dose (ID) of each virus genotype 185 
were performed using identical methodology, differing only in the doses of virus 186 
administered and number of fish in each group, as shown in Table 1. The fish in the 187 
three ID experiment were from three different lots, with an average weight of 1.6 g, 1.1 188 
g, and 1.1 g respectively. In each experiment, groups of fish were exposed to a range 189 
of specific concentrations of virus, or mock exposed, by a 1 hour batch immersion in 190 
static water (Garver et al., 2006). Water flow was then turned on and the fish were 191 
washed for 1 hour. After the wash, the fish were isolated into 1 liter beakers containing 192 
400 ml static water, well before detectable replication or shedding of the virus occurred, 193 
to avoid cross-infection, and then held in isolation at 15 °C for three days, which is 194 
when the mean viral load has previously been shown to reach maximum levels (Troyer 195 
et al., 2008; Peñaranda et al., 2009). At this point each fish was euthanized, harvested 196 
aseptically, and stored in an individual Whirl-pak™ at -80 °C until RNA extraction and 197 
viral load quantification. 198 
  199 
2.3. RNA extraction and cDNA synthesis 200 
 201 
 Total RNA was extracted from whole fish as previously described (Wargo et al., 202 
2010). Briefly, 4 ml/g fish of guanidinium thiocyanate-based denaturing solution was 203 
added to each fish, and the fish was homogenized using a Seward Stomacher® 80 204 
(Biomaster). RNA was extracted from 1 ml of the homogenate with phenol-chloroform, 205 
precipitated, resuspended in 50 µl of water, and assessed for quality and concentration 206 
by spectrophotometry. The RNA samples were then stored at -80 °C until cDNA 207 
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synthesis using M-MLV reverse transcriptase with random heximer primers, as 208 
previously described (Wargo et al., 2010). A standard amount of 5 µL of RNA was used 209 
in each cDNA reaction and the final 20 µl of cDNA was diluted 1:10 in 180 µl of water.   210 
 211 
2.4. Viral RNA quantification via qPCR 212 
 213 
 Viral load of HV or LV in each fish was quantified using genotype-specific qPCR 214 
assays as previously described (Wargo et al., 2010). Briefly, 5 µl of each diluted cDNA 215 
sample was combined with forward and reverse primer and Taqman probe specific for 216 
either HV or LV and then amplified on a 7900HT ABI Prism machine. Since each fish 217 
was exposed to only one genotype, each cDNA sample was tested only for the 218 
genotype expected. Transcript RNA standards specific to each virus genotype were used 219 
for determining absolute viral RNA copy number.  Verification of parity between the two 220 
genotype-specific assays has been reported previously (Wargo et al., 2010). These 221 
assays detect both genomic and messenger RNA (Purcell et al., 2006), and this 222 
combined quantity will be referred to as viral load per gram of host tissue. 223 
 224 
2.5. Virus challenge to determine lethal dose for fish held in isolation  225 
 226 
 The lethal dose in isolation (LD-isolation) was determined by challenging fish in 227 
batch as described above and then holding them in isolation for 30 days. These 228 
experiments were performed on the same lot of fish as the third ID experiment, 229 
approximately three months later. Groups of 20 fish with average weight 1.2 g were 230 
challenged by batch immersion in 1 L of static water containing one of three specific 231 
doses of HV or LV, as shown in Table 1. In addition, one group of 20 control fish was 232 
mock-exposed. After the 1 hour challenge, the water was turned on for a one-hour 233 
rinse, and then individual fish were netted into 1.5 L tanks in a tower rack system 234 
(Aquatic Habitats). These tanks provided independent flow-through water for each fish. 235 
After isolation, the fish were monitored daily for a period of 30 days at 15 °C. Each 236 
treatment group had a total of 20 fish, except for LV at the 104 plaque-forming units 237 
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(PFU)/ml dose and HV at the 103 PFU/ml dose, which both had 19 fish. To confirm virus 238 
as cause of death, plaque assays were performed on approximately 50% of the fish 239 
that died during the experiment (Burke & Mulcahy, 1980; Batts & Winton, 1989). 240 
 241 
2.6. Virus challenge to determine lethal dose for fish held in batch 242 
 243 
 Fish pathogen mortality experiments are traditionally done in batch with replicate 244 
groups of fish held together for the duration of the experiment. While batch conditions 245 
are believed to most closely mimic natural conditions, they differ from the isolation 246 
conditions used to determine infectivity, and these differences could potentially impact 247 
virulence. For example, while the initial doses for batch and isolation treatments are the 248 
same, over the course of the experiment the fish held in batch have the potential to 249 
transmit virus to each other. As such, fish in the batch conditions may receive further 250 
exposure to virus that is not possible in the isolation conditions. Batch conditions also 251 
potentially have different stressors for the fish than isolation conditions. Therefore, in 252 
order to address questions about the differences in mortality assessed in different 253 
holding conditions and to more directly compare results with previous data (Troyer et 254 
al., 2008; Wargo et al., 2010; Wargo & Kurath, 2011; Kell et al., 2013), a lethal dose 255 
experiment in which fish were held in replicate batch groups was conducted in addition 256 
to the one in which they were held in isolation conditions. 257 
The batch lethal dose experiment (LD-batch) was performed simultaneously with 258 
the LD-isolation experiment described above. The procedure is similar to that described 259 
in Wargo et al., 2010 and Breyta et al., 2014. Triplicate groups of 20 fish were 260 
challenged along with the LD-isolation fish, in addition to one group of 20 control fish 261 
that were mock-exposed. After 1 hour of exposure, the water was turned on and 262 
allowed to flow for the duration of the experiment. Fish were held in groups of 20 and 263 
daily monitoring for mortality proceeded for 30 days at 15 °C, as in the LD-isolation 264 
experiment. One of the tanks of LV at 104 PFU/ml had a malfunction and was lost, so 265 
this treatment had duplicate tanks. Approximately 20% of the fish that died were 266 
titered for virus by plaque assay as above. 267 
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 268 
2.7. Statistical analyses 269 
 270 
 The infection and mortality data were used to calculate the projected doses at 271 
which fifty percent of fish were infected (ID50), died in isolation (LD50-isolation), or died 272 
in batch (LD50-batch). The calculations of ID50 and LD50 values were both done using 273 
generalized linear models (GLM) in the statistical program R, version 3.3.1 (R Core 274 
Team, 2015), using the dose.p function of the Mass package (Venables & Ripley, 2002) 275 
with a quasibinomial distribution prior, as described in Breyta et al., 2014. To calculate 276 
the ID50 values, numbers of infected versus uninfected fish were quantified. To 277 
calculate LD50 values numbers of dead versus alive fish were quantified. Significant 278 
differences between the suite of ID50 and LD50 values generated were calculated using 279 
the Welch-Satterthwaite 2-tailed t-test in R (Breyta et al., 2014). Results from the LD 280 
experiments indicated that mortality did not bracket 50% in all cases, leading to 281 
uncertainty in the calculated LD50 value. Therefore, using the same methods, we 282 
calculated the doses at which 25% of the fish exposed to LV died (LD25) and the doses 283 
at which 75% of the fish exposed to HV died (LD75). Differences in the kinetics of 284 
mortality were assessed using Kaplan-Meir curve and log-rank test functions of the 285 
Survival package of R (Therneau 2015), comparing the pooled doses of each treatment 286 
against each other. Viral load data were compared using a generalized linear model 287 
with response variable log-transformed viral load and explanatory factors virus 288 
genotype (HV vs. LV), challenge dose, and experiment. A Tukey multiple comparison of 289 
means test was used to determine differences between factors levels. 290 
 To determine if the relationship between proportion of fish infected and 291 
challenge dose fit the independent action hypothesis (also referred to as mass-action 292 
principle) the method suggested in (Regoes et. al., 2003) was utilized. To do so, the 293 
challenge dose and percent fish infected data from all infectivity experiments was fit to 294 
an independent action hypothesis model (         ) and an interaction hypothesis 295 
model (         
 
), where f = proportion of fish infected from raw data, 1 = the 296 
maximum proportion of fish that can become infected, b = infection rate determined 297 
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from model fit, d = challenge dose, and k = interaction term determined from model fit.  298 
If k = 1 this indicates virions act independently of each other, and thus supports the 299 
independent action hypothesis. If k<1 this suggests there is an antagonistic interaction 300 
between virions such that as more virions are added they each have a harder time 301 
infecting the host. If k>1 this indicates there is a synergistic interaction between virions 302 
such that as more virions are added they each have an easier time infecting the host.  303 
The models were fit to the data using the function “nls” in R version 3.2.0, to calculate 304 
values for b and k. Whether or not the data had a significantly better fit to the 305 
interaction model or the independent action model was then determined using an F-test 306 
with the “anova” function in R. This was further evaluated by determining if 1.96X the 307 
standard error of k overlapped with 1. These analyses were conducted for genotypes 308 
HV and LV separately, to determine if the relationship between challenge dose and 309 
proportion of fish infected was different for the two genotypes.  310 
 311 
3. Results 312 
 313 
3.1. Determination of infectious dose for high and low virulence genotypes, HV and LV 314 
 315 
3.1.1. Infection prevalence in three infectious dose (ID) experiments 316 
 The first ID experiment tested a broad range of challenge doses from 101 to 317 
2x105 PFU/ml. The results indicated that HV and LV functioned similarly with respect to 318 
the percent of fish infected at each dose (Figure 1A), such that for both genotypes no 319 
fish were infected at the lowest dose and there was 100% infection at the highest dose. 320 
At the 103 and 104 PFU/ml doses, although LV had a lower frequency of infection than 321 
HV, the differences corresponded to only one fish and were not significant (p > 0.05). 322 
In the second experiment we tested additional doses in the 103 to 104 PFU/ml range 323 
(Figure 1B). HV infectivity was reproducible for the two doses tested in both 324 
experiments, 103 and 104 PFU/ml. The additional doses in between 103 and 104 PFU/ml 325 
resulted in a regular increase in percent infection with HV. For LV, however, the percent 326 
of fish infected in the second experiment was lower overall than in the first experiment, 327 
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and there was no dose response between 5x103 and 104 PFU/ml. In the third 328 
experiment, the overall frequencies of infection were higher for both HV and LV than in 329 
the previous two experiments (Figure 1C). For HV the percent infection increased more 330 
rapidly between the 5x102 and 103 PFU/ml doses, compared with the first and second 331 
experiments, and then slowly climbed as the dose increased, reaching 100% infection 332 
at 104 PFU/ml as before. LV, in contrast with the second experiment, exhibited a more 333 
regular stepwise increase in infection rate along the entire dose range, similar to the 334 
manner of increase seen for HV in the three experiments, though at lower infection 335 
frequencies. Overall, the percent of fish infected with LV was lower than HV at all doses 336 
in experiment 3, and LV never reached 100% infection, even at 105 PFU/ml. 337 
 338 
3.1.2. Analysis of infectivity data 339 
 The results of all three ID experiments were used to determine the minimum 340 
infectious dose observed. For LV, the lowest dose that caused infection was 103 PFU/ml 341 
in experiments 1 and 3, and 2.5x103 PFU/ml in experiment 2. For HV the minimum 342 
infective dose was 5x102 PFU/ml in experiments 2 and 3 and 103 PFU/ml in experiment 343 
1 where the 5x102 PFU/ml dose was not tested. This data also gives an estimate of the 344 
probability of infection at the minimum dose where infection was observed. For both LV 345 
and HV, this was 10-20%. However, because of the number of fish used in each 346 
experiment, differences in probability less than 10% in experiments 1 and 2 and 347 
differences less than about 7% in experiment 3 cannot be resolved. 348 
The percent infection data from each experiment was then used to calculate 349 
50% infectious dose (ID50) values for both genotypes (Figure 2). In each experiment, 350 
the ID50 for LV was significantly higher than for HV (experiment 1, t = 13.8, df = 3.01, 351 
p = 0.001; experiment 2, t = 3.38, df = 6.94, p = 0.012; experiment 3, t = 8.33, df = 352 
8.50, p < 0.001). Therefore, a lower dose is needed to infect 50% of fish with HV than 353 
with LV. We also calculated the mean of the ID50 values from the three experiments as 354 
9.83x103 PFU/ml for LV and 1.94x103 PFU/ml for HV (Figure 2). The significant 355 
difference between the genotypes remained (t = 4.76, df = 33.5, p < 0.001). By these 356 
measures, HV is approximately 5-fold more infectious than LV.  357 
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 358 
3.1.3. Viral load data from infectivity experiments 359 
 Overall, the viral load data for all virus-positive fish from all the ID experiments 360 
were similar across dose and genotype (Figure 3). While the viral loads of individual fish 361 
did vary, there were almost no significant differences between the means of the log-362 
transformed viral loads, either between doses or between genotypes (p > 0.05). The 363 
one exception was in the first experiment, where the combined mean viral load for both 364 
HV and LV at 104 PFU/ml was significantly lower than the combined mean viral load at 365 
2x105 PFU/ml (F2,34 = 1.87, p = 0.0108). 366 
 367 
3.2. Virulence experiments in HV and LV 368 
 369 
3.2.1. Determination of lethal dose in isolation 370 
The final mortality for LD-isolation ranged between 42-60% for HV and 20-26% 371 
for LV (Figure 4A). For HV, mortality in the 105 PFU/ml dose was higher than the 103 372 
and 104 PFU/ml doses, which were similar in final mortality. However, the kinetics for all 373 
three doses of HV showed a clear dose response; the highest dose had the most rapid 374 
mortality initially, and the lowest dose initially had the slowest mortality. For LV, there 375 
was no strong dose response in either kinetics or final mortality. Although mortality in 376 
the mock treatment group was 15%, all three fish that died were negative for IHNV via 377 
plaque assay. The level of mortality in the mock treatment groups indicated that there 378 
might have been elevated non-specific mortality in the virus-exposed fish as well. 379 
However, all mortalities titered from the virus-exposed groups (approximately 50% of 380 
all fish that died) were positive via plaque assay, with average log-transformed titers of 381 
6.61 ± 0.40 standard error PFU/ml for HV and 6.50 ± 0.27 standard error PFU/ml for 382 
LV. These virus titers are in the range commonly seen in fish that die after IHNV 383 
exposure (Breyta et al., 2014), indicating that they died as a result of viral infection. 384 
 385 
3.2.2. Determination of lethal dose in batch 386 
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 Mortality curves for LD-batch were generated from the daily average cumulative 387 
percent mortality of the three replicate tanks for each genotype and dose, with the 388 
exceptions of the LV 104 PFU/ml dose, which had duplicate tanks, and the mock-389 
infected group, which only had one tank (Figure 4B). For HV, the average mortality 390 
ranged from 60-78%. However, there was not a clear dose response for the 103 and 391 
104 PFU/ml doses, both of which had similar kinetics of mortality. The mortality for the 392 
three doses of LV ranged from 32-47% and followed a clearly separated dose response 393 
in both kinetics and final mortality. When comparing virulence in batch to that in 394 
isolation, for HV the final mortality at each dose was 15-18% higher in batch, and for 395 
LV it was 12-14% higher for the 103 and 104 PFU/ml doses and 22% higher for the 105 396 
PFU/ml in batch. Neither genotype bracketed 50% final mortality; HV mortality was all 397 
above 50%, and LV mortality was all below 50%. One fish died in the mock treatment 398 
group and it was negative for virus via plaque assay. Approximately 20% of the virus-399 
exposed fish that died were tested for virus and all were positive, with average log-400 
transformed titers of 6.29 ± 0.019 standard error PFU/ml for HV and 5.80 ± 0.70 401 
standard error PFU/ml for LV. 402 
 403 
3.2.3. Analysis of mortality data 404 
 Differences in virulence between HV and LV were assessed by survival analysis 405 
on data from the lethal dose experiments.  Log rank tests on the combined Kaplan-406 
Meier estimates for dose and genotype indicated that mortality was significantly higher 407 
for HV than LV, both in isolation (χ2 = 8.4, df = 1, p = 0.0037) and in batch (χ2 = 27.4, 408 
df = 1, p <0.001). This confirms the expected phenotypic difference in virulence 409 
between HV and LV. Additionally, mortality for both HV and LV was significantly higher 410 
in batch than in isolation (χ2 = 5.9, df = 1, p = 0.015 and χ2 = 4.7, df = 1, p = 0.031, 411 
respectively).  412 
 The 50% lethal dose (LD50) values were calculated in the same manner as the 413 
ID50 values (Figure 5). For both lethal dose experiments the calculated LD50 values for 414 
genotypes HV and LV did not differ significantly (P>0.05), despite differing by more 415 
than 8 orders of magnitude for LD50-isolation, and 2 orders of magnitude for LD50-416 
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batch. This is likely because neither HV nor LV bracketed 50% mortality across the 417 
exposure doses, with the exception of HV in isolation, and they fell on opposite sides of 418 
the 50% level (Figure 4). Therefore, calculating LD50 values required inferring the 419 
relationship between dosage and mortality outside the range of available data, leading 420 
to wide 95% confidence intervals. Furthermore, the calculated LD50 above 1012 pfu/ml 421 
for LV in isolation suggested that there is no feasible dose of LV that would be able to 422 
cause 50% mortality under isolation conditions.  In light of this, we also calculated LD25 423 
and LD75 values that were bracketed by the LV and HV data respectively (Figure 5). 424 
This gives us the most accurate values for each genotype. 425 
 426 
3.3. Independent action hypothesis test 427 
Analysis of our infectivity data indicated that the relationship between virus 428 
challenge dose and the proportion of fish infected was better explained by the 429 
independent action hypothesis compared to the interaction hypothesis, for both 430 
genotype HV and LV (Figure 6). This result was supported by a F-test comparison of the 431 
data fit to the two models (Anova; HV: F1,17=0.28, p=0.6; LV: F1,17=0.26, p=0.6), as well 432 
as determination that there was insufficient evidence to indicate the interaction term, k 433 
was significantly different from 1, for either genotype (HV: k = 0.868 ± 0.24; LV: k = 434 
1.26 ± 0.51; gives mean ± 1 standard error), in the formula          
 
 (described in 435 
methods). As such, the results suggest that the infection process operates under a 436 
similar mechanism for HV and LV where individual virions do not inhibit or enhance the 437 
infectivity of other virions. Furthermore, both genotypes were able to achieve 100% of 438 
fish infected at high dosages, supporting the usage of a value of 1 for the maximum 439 
proportion of fish infected in the model. However, the analysis did reveal that the 440 
infectivity rate parameter (b) was 3-fold higher for HV (b= 2.55 x10-4 proportion fish 441 
infected/PFU virus ± 0.55 x 10-4; mean ± 1 standard error) compared to LV (b= 8.00 x 442 
10-5 proportion fish infected/PFU virus ± 1.57 x 10-5). This indicates that infection 443 
increases more quickly as virus exposure dose increases, for HV compared to LV. 444 
 445 
4. Discussion 446 
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 447 
 This study was designed to provide data on how infectivity relates to virulence 448 
for two well-studied IHNV genotypes that are known to differ in both in-host fitness and 449 
virulence (Wargo et al., 2010; Wargo & Kurath, 2011). Overall, the results consistently 450 
showed that HV had a higher infectivity than LV, which correlated with its confirmed 451 
higher virulence. Furthermore, HV showed a more rapid increase in infectivity with 452 
increasing exposure dosage, compared to LV, as indicated by the dose response data 453 
and the independent action model. The previously documented replicative fitness 454 
difference between HV and LV (Wargo 2010; 2011) also correlated with the increased 455 
infectivity shown here. This confirms the finding from previous work (Wargo & Kurath, 456 
2011) that HV has an advantage over LV in host entry, based on comparison of in-host 457 
fitness differences after viral infection by immersion versus injection. This advantage is 458 
likely to be most pronounced at an intermediate range of viral exposure doses, because 459 
at very high or very low doses infection saturated at 100% or 0% for both genotypes 460 
(Figure 1A). Thus neither genotype should have an advantage over the other in the 461 
number of fish that become infected at extreme high or low doses, but at intermediate 462 
dosage HV is predicted to infect more fish than LV, and thus have greater overall 463 
fitness.   464 
A previous investigation of IHNV in fish farms found that virus titers in water 465 
prior to an epizootic range from undetectable to 0.07 PFU/ml, and in the early stages of 466 
an epizootic titers were measured at around 50 PFU/ml (Zhang & Congleton, 1994). At 467 
these low levels, our data suggests infection is unlikely to occur with either genotype, 468 
so fitness differences would not be realized. However, because our sample sizes were 469 
between 10-15 fish, our data cannot resolve differences less than 7-10%, and it may be 470 
that even at the low doses tested there are quantitatively small but biologically relevant 471 
differences in infectivity, especially when fish population sizes are large. Additionally, 472 
the duration of exposure in the current experiment was one hour, and exposure times 473 
in the field are likely much longer, perhaps measured in days or weeks. Although the 474 
relative ability to infect given longer exposure times has not been well characterized, we 475 
have observed that for IHNV a longer immersion exposure does result in a higher 476 
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prevalence of infection (Troyer et al., 2008). This was further supported by the viral 477 
load data in the present study. Here, there were no differences observed in the viral 478 
load of infected fish between genotypes HV and LV. However, a previous study found 479 
within-host viral loads for genotype HV were consistently higher than for LV, and a 480 
larger proportion of fish were infected at the 104 PFU/ml challenge dose (Wargo et al., 481 
2010; Wargo & Kurath 2011). The primary difference between these studies was that in 482 
the previous work, fish were exposed to virus for 12 hours, whereas they were exposed 483 
for 1 hour, and viral load was quantified 12 hours earlier, in the current study. It may 484 
be that the longer immersion challenge allows for infection by more virions, resulting in 485 
faster viral replication kinetics that result in different viral loads, but further research is 486 
needed to discern the effects of exposure time on infection and viral load.  487 
In order to link infectivity and mortality data, we conducted LD experiments in 488 
conjunction with the third ID experiment. The results indicated that the processes of 489 
infection and virulence respond differently to variation in exposure dose. In almost all 490 
cases percent infection increased with increasing dose at a different rate than percent 491 
mortality, and infection prevalence was higher than mortality (Figure 7).  Furthermore, 492 
large increases in percent infection as dose increased were associated with relatively 493 
small increases in percent mortality. The exception to this was for the increase from the 494 
104 PFU/ml to the 105 PFU/ml dose of HV, where no increase in percent infection was 495 
possible due to infection being at 100% at both doses, but there was an increase in 496 
mortality by 15%. This implies that the exposure dose can influence mortality even 497 
when all fish are infected. The calculated LD50 values also supported the conclusions 498 
that infection does not guarantee death in that ID50 values were lower than the LD50 499 
values in nearly all cases (Figure 8). This indicates it takes more virions to kill than to 500 
infect the same number of fish and that while infectivity plays a role in determining 501 
virulence, it is likely not the only factor. 502 
It was interesting that despite the significant differences in virulence between HV 503 
and LV by survival analyses, the calculated LD50 estimates did not differ significantly for 504 
either lethal dose experiment. This was largely because mortality did not bracket 50% 505 
for either genotype and thus uncertainly around the calculated LD50 values was large.  506 
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This implies that significant differences between LD50 values may be difficult to obtain 507 
for virus genotypes that cause widely different levels of mortality. Thus, while this study 508 
is consistent with previous publications that virulence is correlated with previously 509 
demonstrated differences in fitness for IHNV (Peñaranda et. al., 2009; Wargo et. al., 510 
2010; Wargo & Kurath, 2011), these results stress the importance of considering 511 
survival kinetics when quantifying virulence. 512 
 The combination of batch versus isolation virulence experiments made it possible 513 
to examine how holding conditions impact mortality. The difference between percent 514 
mortality in the two holding conditions was consistently 12-22% higher in batch across 515 
the challenge doses for both genotypes. This might be due in part to the fact that in 516 
batch, infected fish are shedding virus into the water, which could be responsible for 517 
multiple rounds of infection. The fact that the 103 PFU/ml dose of LV had a higher rate 518 
of mortality than infection supports this theory (Figure 6). However, the fact that the 519 
104 and 105 PFU/ml doses of HV both had 100% infection, yet there was still an 520 
increase in mortality, suggests that other factors might also be involved. Furthermore, 521 
one would expect the increase in mortality due to multiple rounds of infections to be 522 
greatest when the fewest number of fish were initially infected, for example at the 103 523 
PFU/ml dose, because a large number of fish are remaining for potential infection. 524 
However the increase in mortality between batch and isolation was surprisingly 525 
consistent, regardless of how may fish were initially infected. Constant exposure to 526 
virus could force the infected fish to divert resources to fighting the exposure, which 527 
allows the established infections to cause a higher incidence of mortality. It is 528 
reasonable to consider that manner of exposure (i.e. through shedding or original 529 
inoculum) could play a significant role in mortality rate, just as longer exposure times 530 
resulted in higher infection frequencies and different viral loads in previous studies for 531 
IHNV (this study compared with Wargo & Kurath, 2011). Additionally, the batch and 532 
isolation treatments imposed different stressors on the fish, which could have affected 533 
mortality rates differently. High fish density in hatcheries increases probability of 534 
contact between infected fish and has been linked to increased stress and lower water 535 
quality (Bootland & Leong, 2011). However, rainbow trout are also social animals and 536 
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moving individual fish to isolation may be a stressor (Øverli et al., 2002; Øverli et al., 537 
2005). Determining the role of stress, holding conditions, and multiple rounds of 538 
transmission in driving IHNV induced fish mortality warrants further study. 539 
In this study we have illuminated a previously unexplored relationship between 540 
infectivity and virulence in an aquatic virus. We have shown that while infectivity does 541 
indeed correlate with virulence, it does not appear to be the only driving factor. To our 542 
knowledge, such detailed work comparing infectivity and lethality has not been done 543 
with IHNV in rainbow trout or with any other fish pathogen; as such it can serve as a 544 
point of comparison for future studies. Due to variation in absolute mortality levels 545 
observed in IHNV virulence studies repeated in different years (Breyta et al., 2014), it is 546 
valuable to have infectivity and mortality data from the same year with the same lot of 547 
fish. This was also evident in the current study, as some variation in infectivity was 548 
observed between experiments conducted with different lots of fish. In future work 549 
similar studies with other viral strains in multiple hosts will help determine if infectious 550 
dose is as variable as lethal dose across different viral strains, and if infectivity and 551 
lethality vary in the same manner. Examination of the exposure dose response of 552 
mortality and infection also makes it possible to characterize heterogeneity of host 553 
susceptibility (Rodrigues et. al., 2009). This is essential for understanding 554 
epidemiological patterns and can greatly enhance pathogen control (Gomes et. al., 555 
2014). For example, our study suggested that the relationship between infectivity and 556 
exposure dose fits the independent action hypothesis. However, it is possible that virion 557 
interactions do occur but this was masked by susceptibility heterogeneity (Rogeos et. 558 
al., 2003; van der Werf, et. al., 2011). More importantly, this work clearly shows that 559 
infectivity and virulence differences between pathogen strains may not be evident at 560 
very high or very low exposure doses, and thus it is important to examine a range of 561 
exposure doses to determine where fitness differences are the most important. The 562 
evolutionary implications of this dose response to pathogen fitness differences warrant 563 
consideration. In summary, this work has demonstrated that for IHNV in rainbow trout 564 
viral infectivity is positively correlated with virulence, but the ID50 values varied less 565 
than the LD50 values. This serves as a valuable example of the relationship between 566 
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viral infectivity and virulence in a naturally co-evolved vertebrate host-pathogen 567 
association. 568 
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Experiment Fish lot Exposure doses  
(PFU/ml) 
# fish/dose/strain 
(at initial batch 
challenge) 
Experiment 
duration 
# fish/tank  
(for holding) 
Infectious dose 1 1 101, 102, 103, 104, 2x105 10 3 days 1 individual 
Infectious dose 2 2 5x102, 103, 2.5x103, 5x103, 
7.5x103, 104, 105 
10 3 days 1 individual 
Infectious dose 3 3 5x102, 103, 2.5x103, 5x103, 
7.5x103, 104, 105 
15 3 days 1 individual 
Lethal dose, 
isolation 
3 103, 104, 105 20 30 days 1 individual 
Lethal dose, 
batch 
3 103, 104, 105 3 groups of 20 30 days 20 grouped 
 711 
Table 1: Infectious dose and lethal dose experimental designs. All experiments had a 1-hour immersion challenge in 712 
batch. The “Experiment duration” and “# fish/tank” columns describe the holding conditions after the 1-hour challenge. 713 
Exposure doses are given in plaque-forming units (PFU) per milliliter. 714 
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Figure 1: Percent infection data from infectious dose experiments. In all panels, LV is 
gray and HV is black. In A and B, n=10; in C, n=15. Note that the x-axis dose values in 
A are different than those of B and C. 
 
Figure 2: 50% infectious dose (ID50) values. The combined ID50 represents the mean of 
log base 10 transformed ID50 values from the first three experiments. The error bars 
show the 95% confidence interval. In each experiment, the difference between the LV 
ID50 and HV ID50 was statistically significant (p < 0.05). 
 
Figure 3: Viral load data from infectious dose experiments. In all panels, LV is gray and 
HV is black. In A and B, n=10; in C, n=15. Data presented as mean of log base 10 
transformed viral load (+/- 1 standard error), at various exposure doses. Only virus-
positive fish are included in the mean, the number of which is indicated by the values 
above the bars. 
 
Figure 4: Mortality curves from the lethal dose experiments. A: Mortality from the LD-
isolation experiment with fish in individual tanks.  B: Mortality from the LD-batch 
experiment. For B, data points show the average mortality of three tanks of 20 fish for 
each dose and genotype, with the exception of the mock group, which had only a single 
tank, and the LV 104 PFU/ml dose, which had two tanks. Error bars show the standard 
error. 
 
Figure 5: Comparison of LD25, LD50, and LD75 values from both isolation and batch 
virulence experiments in units of log of PFU/ml. Values from LD-isolation are on the left; 
values from LD-batch are on the right. For LV, the two bars indicate the LD25 and LD50 
values, and for HV the two bars indicate the LD50 and LD75 values. The error bars show 
the 95% confidence interval. 
 
Figure 6: Comparisons of percent infected and percent mortality values at the three 
challenge doses used in the ID-3, LD-isolation and LD-batch experiments. Percent 
infected data is from experiment 3, which was performed on the same lot of fish as the 
Figure legends
LD-isolation and LD-batch experiments. LV is on the left, in gray, and HV is on the right 
in black. The batch mortality values represent the mean of triplicate tanks (+/- 1 
standard error). 
 
Figure 7: Comparisons between ID50 and LD50 values for each strain. On the left in gray 
is LV, and on the right in black is HV. The ID50 values shown are calculated from the 
third experiment, which was done on the same lot of fish as the LD50 experiments. The 
error bars indicate the 95% confidence interval. 
 
Figure 8: Test of Independent Action Hypothesis.  Data points show relationship 
between challenge dose (x-axis) and proportion of fish infected (y-axis), for genotypes 
HV (black circles) and LV (grey squares).  Thick solid line is the independent action 
model (𝑓 = 1 − 𝑒−𝑏∗𝑑) fit to the data for HV (black) and LV (grey).   Thin dotted line is the 
interaction model fit (𝑓 = 1 − 𝑒−𝑏∗𝑑
𝑘
) to the data for HV (black) and LV (grey).  Where f = 
proportion of fish infected from raw data, 1= the maximum proportion of fish that can 
become infected, b=infection rate determined from model fit, d=challenge dose, and k = 
interaction term determined from model fit. k = 1 indicates independent action, k<1 
indicates antagonistic interaction, and k>1 indicates synergistic interaction.  For the 
independent action model b = 2.55 x10-4 ± 0.55 x 10-4 and 8.00 x 10-5 ± 1.57 x 10-5 
proportion fish infected/PFU virus, for HV and LV respectively (value ± 1 standard 
error).  For the interaction model b = 7.61 x10-4 ± 15.20 x 10-4 and 7.71 x 10-6 ± 35.47 x 
10-5 proportion fish infected/PFU virus; and k = 0.868 ± 0.240 and 1.26 ± 0.51, for HV 
and LV respectively (value ± 1 standard error).  As such, k overlapped with 1 for both 
HV and LV, supporting independent action model.  There was no significant difference 
in model fit between independent action and interaction models by anova (HV: 
F1,17=0.28, p=0.6; LV: F1,17=0.26, p=0.6), so null hypothesis of independent action could 
not be rejected.  Data was fit to models using “nls” function in the R programming 
language. 
